(Press-News.org) Smokers of mentholated cigarettes are no more likely to develop lung cancer than other smokers, according to a new, very large, prospective study of black and white smokers published online March 23 in the Journal of the National Cancer Institute. In fact, contrary to a popular hypothesis, menthol smokers in this study had a somewhat lower risk of developing and dying from lung cancer than non-menthol smokers.
Lung cancer rates are higher among blacks than whites, and use of mentholated cigarettes, also higher among blacks, has been suggested as a possible explanation. Some studies have raised the possibility that menthol influences smoking behavior, causing deeper inhalation for instance, or that it increases dependency or affects the biology of the lung. Others have suggested that menthol makes it harder to quit smoking.
To explore these issues, William J. Blot, Ph.D., of the Vanderbilt-Ingram Cancer Center in Nashville, Tenn., and the International Epidemiology Institute, Rockville, Md., and colleagues conducted a prospective study among 85,806 people enrolled in the Southern Community Cohort Study, an ongoing multiracial study in 12 southern states. Within this cohort, they identified 440 lung cancer patients and compared them with 2,213 matched controls (other people in the study with the same demographics, such as race, age, and sex, but without lung cancer).
They found that menthol cigarettes were associated with a lower lung cancer incidence and fewer lung cancer deaths than regular cigarettes. For instance among people smoking 20 or more cigarettes a day, menthol smokers were about 12 times more likely to have lung cancer than never-smokers while non-menthol smokers were about 21 times more likely to have the disease. The differences were statistically significant.
The researchers also collected information on smoking behavior, including quitting smoking, among 12,373 participants who smoked and who responded to a follow-up questionnaire. Among both blacks and whites, menthol smokers reported smoking fewer cigarettes per day than non-menthol smokers. After an average 4.3 years of follow up, 21% of those who smoked at the beginning of the study had quit; the quit rate was about the same for menthol and non-menthol smokers.
The authors conclude that mentholated cigarettes are no more, and perhaps less, harmful than non-mentholated cigarettes. They note that the findings are timely, as the U.S. Food and Drug Administration is now considering whether to ban or regulate mentholated cigarettes.
"Cigarette smoking remains the leading cause of premature death in the United States, but undue emphasis on reduction of menthol relative to other cigarettes may distract from the ultimate health prevention message that smoking of any cigarettes is injurious to health," they write.
###
Contact: Dagny Stuart, Vanderbilt-Ingram Cancer Center, dagny.stuart@vanderbilt.edu; 615-936-7245)
Lung cancer study finds mentholated cigarettes no more harmful than regular cigarettes
2011-03-24
ELSE PRESS RELEASES FROM THIS DATE:
2 new targets for melanoma therapies
2011-03-24
The latest clues suggesting potential new ways to treat melanoma come from an unlikely source: fish.
Zebrafish don't get sunburns, but they can get skin cancer – at least those fish that have been engineered to model the often deadly human cancer. When Leonard Zon, a Howard Hughes Medical Institute investigator at Children's Hospital Boston, developed this melanoma model five years ago, he hoped to use the tiny striped fish to discover new melanoma genes or new therapies for this aggressive cancer that consistently eludes treatment.
Now, in work described in two papers ...
First look at the full multiple myeloma genome reveals new insights, discoveries
2011-03-24
Scientists have unveiled the most comprehensive picture to date of the full genetic blueprint of multiple myeloma, a form of blood cancer. A study of the genomes from 38 cancer samples has yielded new and unexpected insights into the events that lead to this form of cancer and could influence the direction of multiple myeloma research. This work, led by scientists at the Broad Institute and Dana-Farber Cancer Institute, appears in the March 24 issue of Nature.
Multiple myeloma is the second most common blood cancer in the United States and causes about 20,000 new cases ...
Drug prevents Type 2 diabetes in majority of high-risk individuals
2011-03-24
SAN ANTONIO, Texas, U.S.A. (March 24, 2011) — A pill taken once a day in the morning prevented type 2 diabetes in more than 70 percent of individuals whose obesity, ethnicity and other markers put them at highest risk for the disease, U.S. scientists reported today.
The team also noted a 31 percent decrease in the rate of thickening of the carotid artery, the major vessel that supplies blood to the brain. The study, which enrolled 602 participants through The University of Texas Health Science Center San Antonio and seven collaborating centers, is described in the New ...
Mouse cancer genome unveils genetic errors in human cancers
2011-03-24
Scientists who pioneered sequencing the genomes of cancer patients to find novel genetic changes at the root of the disease now have turned their attention to a laboratory workhorse — a mouse.
By sequencing the genome of a mouse with cancer, researchers at Washington University School of Medicine in St. Louis have uncovered mutations that also drive cancer in humans. The investigators are the first to sequence a mouse cancer genome, and their research is reported online March 23 in the Journal of Clinical Investigation.
"This approach gives us a way to rapidly evaluate ...
New insight into how environmental enrichment enhances memory
2011-03-24
It is well established that environmental enrichment, providing animals with rich sensory, motor, and social stimulation, produces both dramatic increases in the number of synapses in the brain and enhanced learning. However, causal relationships between synapse formation and improved memory have not been definitively established. Now, a new study published by Cell Press in the March 24 issue of the journal Neuron introduces a valuable model system for investigating the role of synapse turnover in learning and memory in adult animals and elucidates mechanisms that link ...
The evolution of brain wiring: Navigating to the neocortex
2011-03-24
A new study is providing fascinating insight into how projections conveying sensory information in the brain are guided to their appropriate targets in different species. The research, published by Cell Press in the March 24 issue of the journal Neuron, reveals a surprising new evolutionary scenario that may help to explain how subtle changes in the migration of "guidepost" neurons underlie major differences in brain connectivity between mammals and nonmammalian vertebrates.
The neocortex (the "new" cortex) is a brain area that is unique to mammals and plays a central ...
Mass. General study reveals how lung cancers evolve in response to targeted treatment
2011-03-24
A detailed analysis of lung tumors that became resistant to targeted therapy drugs has revealed two previously unreported resistance mechanisms. In a report in the March 23 Science Translational Medicine, investigators from the Massachusetts General Hospital (MGH) Cancer Center also describe how the cellular nature of some tumors actually changes in response to treatment and find that resistance-conferring mutations can disappear after treatment is discontinued. The findings support the importance of monitoring the molecular status of tumors throughout the treatment process.
"It ...
Red tape for clinical trial consent can be lethal: Experts
2011-03-24
Current rules requiring researchers to obtain consent for patients to take part in clinical trials in emergency situations are causing life-threatening delays to treatment, experts have argued.
They say that in severe trauma cases, waiting for a relative to give written permission is "unethical" because of the importance of prompt treatment.
Professor Ian Roberts, Dr Haleema Shakur and Dr David Prieto-Merino, from the Clinical Trials Unit of the London School of Hygiene & Tropical Medicine, make their point in a letter published in The Lancet.
It is co-signed by Sir ...
Why salad helps you say yes to 'NO'
2011-03-24
Disorders of the circulatory system- vascular diseases- are common in the developed world, and can lead to heart attacks, strokes and even death. However, treatments for these disorders, such as bypass surgery and angioplasty, themselves induce vascular injury, after which the cells of the blood vessel can over-proliferate in a way that limits blood flow. Nitric oxide (NO) is an important molecule that helps maintain the contractility and health of vascular smooth muscle cells, and multiple studies have linked vascular pathology to a decreased level of NO. Therefore, therapies ...
JCI online early table of contents: March 23, 2011
2011-03-24
EDITOR'S PICK
Why salad helps you say yes to NO
Disorders of the circulatory system- vascular diseases- are common in the developed world, and can lead to heart attacks, strokes and even death. However, treatments for these disorders, such as bypass surgery and angioplasty, themselves induce vascular injury, after which the cells of the blood vessel can over-proliferate in a way that limits blood flow. Nitric oxide (NO) is an important molecule that helps maintain the contractility and health of vascular smooth muscle cells, and multiple studies have linked vascular ...